Investors
Analyst coverage
The below listed sell-side analysts currently cover ASML.
| Company | Contact | City |
|---|---|---|
| ABN AMRO | Wim Gille | Amsterdam |
| Agency Partners | Stuart Jeffrey | London |
| Arete Research | Jim Fontanelli | London |
| Bank of America Merrill Lynch | Adithya Metuku | London |
| Barclays | Andrew Gardiner | London |
| Berenberg Bank | Tammy Qiu | London |
| Bernstein | Mark Li | Hong Kong |
| Bryan Garnier | Frédéric Yoboué | Paris |
| Citigroup | Amit Harchandani | London |
| Cowen | Krish Sankar | San Francisco |
| Credit Suisse | Achal Sultania | London |
| DeGroof Petercam | Michael Roeg | Amsterdam |
| Deutsche Bank | Rob Sanders | London |
| Evercore ISI | C.J. Muse | New York |
| Exane BNP Paribas | Jérôme Ramel | San Francisco |
| Goldman Sachs | Alex Duval | London |
| ING | Marc Hesselink | Amsterdam |
| Independent Minds | Andrew Hayman | London |
| InsingerGilissen | Jos Versteeg | Amsterdam |
| JP Morgan | Sandeep Deshpande | London |
| Kempen | Nigel van Putten | Amsterdam |
| Kepler Cheuvreux | Peter Olofsen | Amsterdam |
| KeyBanc | Weston Twigg | Portland (OR) |
| Liberum | Janardan Menon | London |
| MainFirst Bank | Jürgen Wagner | Frankfurt |
| Mizuho | Kevin Wang | Hong Kong |
| Morgan Stanley | Dominik Olszewski | London |
| New Street research | Pierre Ferragu | New York |
| ODDO BHF | Stéphane Houri | Paris |
| RBC Capital | Mitch Steves | San Francisco |
| Santander | Carlos Treviño Peinador | Madrid |
| Societe Generale | Aleksander Peterc | London |
| Susquehanna | Mehdi Hosseini | San Francisco |
| Technology Advisory Group | Warren Lau | Hong Kong |
| UBS | David Mulholland | London |
| Wells Fargo | Joe Quatrochi | St. Louis |
Important legal notice
ASML is followed by the sell-side analysts brokerage firms listed above. The list may not be complete and is subject to change. Please note that any opinions, estimates or forecasts regarding ASML's performance made by the analysts at these firms are theirs alone and do not represent opinions, forecasts or predictions of ASML or its management. ASML does not by listing these firms imply its endorsement of or concurrence with such information, conclusions or recommendations.